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New horizons for the repair of  
skin defects
To the Editor: Visible skin defects in adults, and especially those 
in the developing child, are frequently very unsightly, stigmatising 
the person and often leading to severe psychological sequelae. This 
situation can result from surgical treatment of vitiligo, congenital 
pigmented naevi, vascular hamartomas and skin cancer, and from 
burn scars and contractures. Many affected people are ostracised 
from society because of our inability to restore the defect to normality 
after excision, or at least to an acceptable functional and cosmetic 
end result. The obvious solution is to replace the excised tissue with 
a functional and cosmetic substitute similar to the surrounding area.
An assortment of dermal substitutes is currently commercially 
available to replace these surgical defects. They usually require a 
period of 2 - 3 weeks to vascularise before an epithelial autologous 
skin graft can be done to complete the process.
The Tissue Biology Research Unit at Zurich University has, 
through the EuroSkinGraft Consortium Project, developed a 
bioengineered full-thickness skin graft containing dermal and 
epidermal equivalent components including preformed blood 
capillaries and melanocytes.[1-6] While these grafts lack innervation, 
hair follicles and sweat glands, they are the most complete bio-
engineered skin grafts currently available to treat full-thickness skin 
defects resulting from acute and elective procedures. In preclinical 
trials, rapid take, almost no shrinkage of the graft and excellent 
non-scar remodelling of the skin transplant were achieved.[3,4]
Disfigured people have a burning desire to be normal again. A 
prevascularised pigmented graft would be of immense value in 
surgery performed on darker-skinned people suffering from a broad 
spectrum of disfiguring skin defects. It would be indispensable in 
surgical correction of the depigmented areas of crippling vitiligo 
or healed burn wounds (subject to squamous carcinoma), or to 
reconstruct skin defects following scar and keloid excisions or 
contracture release and repair as a single-stage procedure, without 
delaying autologous skin grafting. The repaired area would have the 
same physical appearance as the surrounding unaffected skin. In the 
future, repair of such defects with equivalent pigmented skin will be 
considered essential to optimise functional and cosmetic outcomes, 
and it will be of indispensable value to those affected.
Pigmented skin-equivalent grafts for patients with darker skins 
have been achieved successfully in experimental circumstances, 
but have not been subject to clinical trials. This is an essential 
regenerative concept with wide therapeutic and practical advantages 
for the future. 
H Rode
Department of Paediatric Surgery, Red Cross War Memorial Children’s Hospital and 
Faculty of Health Sciences, University of Cape Town, South Africa
heinz.rode@uct.ac.za
1. Biedermann T, Bottcher-Haberzeth S, Klar AS, et al. Rebuild, restore, reinnervate: Do human tissue 
engineered dermo-epidermal skin analogs attract host nerve fibers for innervations? Pediatr Surg Int 
2013;29(1):71-78. [http://dx.doi.org/10.1007/s00383-012-3208-1]
514       July 2015, Vol. 105, No. 7
CORRESPONDENCE
515       July 2015, Vol. 105, No. 7
2. Bottcher-Haberzeth S, Klar AS, Biedermann T, et al. ‘Trooping the colour’: Restoring the original donor 
skin colour by addition of melanocytes to bioengeneered skin analogs. Pediatr Surg Int 2013;29(3):239-
427. [http://dx.doi.org/1007/s00383-012-3217-0]
3. Hartmann-Fritsch F, Biedermann T, Braziulis E, Meuli M, Reichmann E. A new model for preclinical 
testing of dermal substitutes for human skin reconstruction. Pediatr Surg Int 2013;29(5):479-488.
[http://dx.doi.org/10.1007/s00383-013-3267-y]
4. Marino D, Reichmann E, Meuli M. Skingineering. Eur J Pediatr Surg 2014;24(3):205-213. [http://
dx.doi.org/10.1055/s-0034-1376315]
5. Marino D, Luginbühl J, Scola S, Meuli M, Reichmann E. Bioengineering dermo-epidermal skin grafts 
with blood and lymphatic capillaries. Sci Transl Med 2014;6(221):221ra14. [http://dx.doi.org/10.1126/
scitranslmed.3006894]
6. Klar AS, Böttcher-Haberzeth S, Schiestl C, Reichmann E, Meuli M. Tissue-engineered dermo-
epidermal skin analogs exhibit de novo formation of a near natural neurovascular link 10 weeks after 
transplantation. Pediatr Surg Int 2014;30(2):165-172. [http://dx.doi.org/10.1007/s00383-013-3446-x]
S Afr Med J 2015;105(7):514-515. DOI:10.7196/SAMJnew.7807
